Showing 251-260 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| β Cell Mitochondrial Health as a Driver and Indicator of Immune Activation in Type 1 Diabetes | Trustees of Indiana University | Carmella Evans-Molina | Cures | 01-March-2026 to 28-February-2029 | $748,179.00 |
| Evaluation of Oxidized Insulin as a Biomarker and Therapeutic Target in Type 1 Diabetes | Trustees of Indiana University | Amelia Linnemann | Cures | 01-October-2023 to 30-September-2026 | $560,000.00 |
| Targeting self-RNA sensing as a trigger of inflammation in type 1 diabetes | Trustees of the University of Pennsylvania | Qin Li | Cures | 01-April-2025 to 31-March-2026 | $199,919.54 |
| Targeted mRNA LNP strategies to modulate lymphocyte migration and Treg function for T1D immunotherapy | Trustees of the University of Pennsylvania | Michael Betts | Cures | 01-September-2024 to 31-August-2027 | $900,000.00 |
| An AI-driven bioelectronics system to accelerate SC-islet maturation | Trustees of the University of Pennsylvania | Juan Alvarez | Cures | 01-April-2025 to 01-March-2027 | $200,000.00 |
| Evaluating gene-modified hypo-immune PSCs for immune evasion in NHPs | Trustees of the University of Pennsylvania | Ji Lei | Cures | 01-June-2025 to 31-May-2027 | $749,999.08 |
| Reducing the Burden of Type 1 Diabetes Using Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances | University of California, San Diego | Schafer Boeder | Improving Lives | 01-July-2022 to 30-June-2027 | $749,956.58 |
| IL-37 expressing Treg cells to improve T1D therapeutic strategy | University of California, San Diego | Mayumi Fujita | Cures | 01-September-2025 to 28-February-2026 | $161,904.81 |
| Microneedle Sensor for Simultaneous Continuous Monitoring of Ketone and Glucose | University of California, San Diego | Joseph Wang | Improving Lives | 01-October-2022 to 30-April-2027 | $867,998.91 |
| The Effects of Glucagon Antagonism on Insulin Resistance, Ketone Production, and Cardiovascular Risk in Individuals with Type 1 Diabetes | University of California, San Diego | Jeremy Pettus | Improving Lives | 01-June-2021 to 30-November-2026 | $1,233,752.52 |